The Primary Ciliary Dyskinesia (PCD) market reflects significant advancements amid complex challenges affecting market dynamics globally. Recent innovations in gene therapy and targeted treatment options are shaping the industry size, while regulatory adaptations and investment flows continue to drive market growth strategies. Evaluating the strategic market landscape is essential to...